Inactive Instrument

Abnova (Taiwan) Corporation. Stock Taipei Exchange

Equities

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
- TWD - Intraday chart for Abnova (Taiwan) Corporation.
Sales 2022 412M 12.68M Sales 2023 382M 11.77M Capitalization 2.13B 65.48M
Net income 2022 74M 2.28M Net income 2023 43M 1.32M EV / Sales 2022 5.2 x
Net cash position 2022 356M 10.96M Net cash position 2023 415M 12.8M EV / Sales 2023 4.48 x
P/E ratio 2022
33.5 x
P/E ratio 2023
48.8 x
Employees -
Yield 2022
1.94%
Yield 2023
2.05%
Free-Float 73.71%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 18-06-30
Chairman 58 -
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 60 20-06-18
Chairman 58 -
Director/Board Member 73 17-06-22
More insiders
ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
More about the company